Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carmoterol Dose Confirmation in COPD
NCT00640484Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Apr 2008; status: completed.
02
Drugs
carmoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00640484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640484.